Dow Up0.08% Nasdaq Down0.30%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.77 Up 0.01(0.17%) Sep 19, 4:00PM EDT
|After Hours : 5.76 Down 0.01 (0.17%) Sep 19, 7:34PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 12,113   11,782   8,353   16,732  
Cost of Revenue2,395  1,288  8,699  416  
Gross Profit 9,718   10,494   (346) 16,316  
Operating Expenses
Research Development31,794  28,554  35,824  45,145  
Selling General and Administrative34,199  31,591  37,638  37,394  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (56,275) (49,651) (73,808) (66,223)
Income from Continuing Operations
Total Other Income/Expenses Net18  (19)(136)31  
Earnings Before Interest And Taxes(56,257)(49,670)(73,944)(66,192)
Interest Expense558  33  35  38  
Income Before Tax(56,815)(49,703)(73,979)(66,230)
Income Tax Expense106  119  184  110  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(56,921)(49,822)(74,163)(66,340)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (56,921) (49,822) (74,163) (66,340)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (56,921) (49,822) (74,163) (66,340)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.